John P. Hamill, Interim CFO at Cellectar Biosciences, holds ― shares in Cellectar Biosciences (Ticker: CLRB), holds 19.37K shares in Aprea Therapeutics (Ticker: APRE), holds 72.80K shares in Windtree Therapeutics (Ticker: WINT). Most recently, John P. Hamill ― shares of Cellectar Biosciences on ― for an estimated value of ―.
What is the percentage of profitable transactions made by John P. Hamill?
The percentage of profitable transactions made by John P. Hamill is 38%.
What is the average return per transaction made by John P. Hamill?
The average return per transaction made by John P. Hamill is -28.40%.
What stocks does John P. Hamill hold?
John P. Hamill holds: CLRB, TRVN, WINT, APRE stocks.
What was John P. Hamill’s latest transaction?
John P. Hamill latest transaction was an Uninformative Buy of ―.
What was John P. Hamill's most profitable transaction?
John P. Hamill’s most profitable transaction was an Informative Buy of APRE stock on October 15, 2024. The return on the trade was 28.50%.
What is John P. Hamill's role in Cellectar Biosciences?
John P. Hamill's role in Cellectar Biosciences is Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.